Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma

Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma

(1) Background: New therapeutic strategies have improved the prognosis of multiple myeloma (MM), changing the accepted view of this disease from being incurable to treatable. (2) Methods: We studied 1001 patients with MM between 1980 and 2020, grouping patients into ten-year periods by diagnosis 198...

Full description

Bibliographic Details
Main Authors: Borja Puertas, Verónica González-Calle, Eduardo Sobejano-Fuertes, Fernando Escalante, José A. Queizán, Abelardo Bárez, Jorge Labrador, José María Alonso-Alonso, Alfonso García de Coca, Alberto Cantalapiedra, Teresa Villaescusa, Carlos Aguilar-Franco, Elena Alejo-Alonso, Beatriz Rey-Bua, Lucía López-Corral, Ramón García-Sanz, Noemi Puig, Norma C. Gutiérrez, María-Victoria Mateos
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Cancers
Subjects:
novel agents
survival
long survivors
Online Access:https://www.mdpi.com/2072-6694/15/5/1558

Similar Items

Similar Items